Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Core Scientific Inc (CORZ) vs Tilray Brands Inc (TLRY) Price & Performance

Core Scientific IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Core Scientific Inc vs Tilray Brands Inc — how do they compare? Core Scientific Inc trades at $22.26 (market cap $7.02B), while Tilray Brands Inc trades at $4.37 (market cap $540.74M). The key difference: Core Scientific Inc is far larger — about 13× Tilray Brands Inc's market cap, and Core Scientific Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.

CORZTLRY
Market Cap
$7.02B$540.74M
Sector
TechnologyHealth
52-Week High
$29.16$21.00
52-Week Low
$12.65$4.31
Enterprise Value
$8.07B$637.89M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Core Scientific Inc

Core Scientific (CORZ) trades at $22.71, down 3.32% today, with a bearish technical signal despite strong analyst support. The company is transitioning from Bitcoin mining to AI colocation, with Q1 2026 colocation revenue surging to $77.5M and gross margins of 57%. However, the company continues to report significant losses with a net income margin of -341.68% and negative cash flow of $525.6M in 2025.

The outlook remains speculative with substantial execution risk despite analyst optimism. While the AI pivot offers growth potential, persistent losses and cash burn present significant challenges. The consensus price target of $34.17 suggests 50% upside potential, but investors must weigh the high-risk transformation against the company's current financial instability.

Tilray Brands Inc

TLRY trades at $4.46, up 0.9% on the day, amid a bearish technical signal and mixed earnings history. The company reported a net loss of $2.19 billion in 2025, with a negative net income margin of -156.67%, though revenue grew to $821.31 million. Analyst consensus is cautious with 65% hold ratings, and recent news highlights expansion in medical cannabis and new product launches.

The outlook remains challenged by persistent losses and high debt levels, but low valuation ratios like P/S of 0.54 and P/B of 0.35 may attract value investors. Key risks include profitability struggles and regulatory uncertainty, while potential catalysts include international expansion and upcoming earnings on July 28, 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Core Scientific Inc

Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.

Read more on CORZ

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY